EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Significance of Inflammatory Markers in Patients with Immune Thrombocytopenia

Nur Oğuz Davutoğlu, Ali İhsan Gemici, Merve Kocaköse, Selçuk Uylaş, Şeyma Tanır, Gökhan Pektaş, Mehmet Bilgehan Pektaş

International Journal of Molecular Sciences · 18.06.2026 · 27 (12) · 5528

DOI: 10.3390/ijms27125528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2026. Verfasst von Nur Oğuz Davutoğlu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Eskişehir City Hospital, Eskişehir 26080, Türkiye. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Biomarkers, Inflammation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is a heterogeneous autoimmune disorder characterized by immune-mediated platelet destruction and impaired platelet production. Increasing evidence suggests that systemic inflammation plays a significant role in disease pathogenesis and clinical outcomes. This study aimed to evaluate the prognostic significance of inflammatory indices and their association with complications, mortality, treatment response, and relapse in patients with ITP. In this single-center retrospective study, 166 adult patients diagnosed with primary ITP between January 2015 and December 2024 were analyzed. Demographic, clinical, and laboratory data at diagnosis were collected. Inflammatory indices derived from complete blood count parameters, including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), were evaluated. Their associations with clinical outcomes were assessed using appropriate statistical methods. During the observation period based on retrospective medical records, complications occurred in 12% of patients, and mortality was observed in 6.6%. Patients with complications had significantly higher D-dimer levels and reduced bone marrow megakaryocyte production. In group comparisons, mortality was significantly associated with advanced age, male sex, and comorbidities. Laboratory findings revealed that lower hemoglobin, lymphocyte count, mean platelet volume, and albumin levels, along with higher PLR, erythrocyte sedimentation rate, bilirubin, and D-dimer levels, were significantly associated with mortality. Inflammatory indices such as NLR and PLR were not associated with complication development, but PLR was significantly associated with mortality. Response to intravenous immunoglobulin (IVIG) therapy was significantly associated with higher total protein, albumin, and fibrinogen levels, and lower erythrocyte sedimentation rate. Relapse was significantly associated in group comparisons with increased inflammatory activity, higher reticulocyte count, and positivity for antinuclear antibodies and Helicobacter pylori antigen. Systemic inflammation and impaired megakaryopoiesis play critical roles in the prognosis of ITP. While conventional inflammatory indices showed limited predictive value for complications, markers such as PLR, D-dimer, and albumin were associated with mortality and clinical outcomes. These findings suggest that readily available laboratory parameters may provide valuable insights for risk stratification and personalized management in patients with ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicBiomarkersInflammationHumansFemaleMalePrognosisAdultMiddle AgedRetrospective StudiesAgedBlood PlateletsNeutrophilsLymphocytesPlatelet CountFibrin Fibrinogen Degradation Products

Stichwörter der Autor:innen

D-dimerimmune thrombocytopeniainflammationplatelet-to-lymphocyte ratio

Substanzen

BiomarkersFibrin Fibrinogen Degradation Products

Autor:innen und Institutionen

  • Division of Hematology, Eskişehir City Hospital, Eskişehir 26080, Türkiye.
  • Division of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Türkiye.
  • Division of Hematology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Türkiye.
  • Department of Medical Pharmacology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03200, Türkiye.

Zitieren

APA

Oğuz Davutoğlu, N., Gemici, A. İ., Kocaköse, M., Uylaş, S., Tanır, Ş., Pektaş, G., & Pektaş, M. B. (2026). Prognostic Significance of Inflammatory Markers in Patients with Immune Thrombocytopenia. International Journal of Molecular Sciences, 27(12), 5528. https://doi.org/10.3390/ijms27125528

Vancouver

Oğuz Davutoğlu N, Gemici Aİ, Kocaköse M, Uylaş S, Tanır Ş, Pektaş G, et al. Prognostic Significance of Inflammatory Markers in Patients with Immune Thrombocytopenia. International Journal of Molecular Sciences. 2026;27(12):5528. doi:10.3390/ijms27125528

BibTeX
@article{OuzDavutolu2026,
  author = {Oğuz Davutoğlu, Nur and Gemici, Ali İhsan and Kocaköse, Merve and Uylaş, Selçuk and Tanır, Şeyma and Pektaş, Gökhan and Pektaş, Mehmet Bilgehan},
  title = {Prognostic Significance of Inflammatory Markers in Patients with Immune Thrombocytopenia},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5528},
  doi = {10.3390/ijms27125528}
}
Kostenlos starten →